We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ATH market cap is 14.5M. The company's latest EPS is AUD -0.0079 and P/E is -1.27.
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 123k | 4.49M | 5.12M | 3.92M | 4.02M |
| Operating Income | -13.82M | -15.1M | -15.5M | -14.64M | -19.61M |
| Net Income | -13.46M | -15.31M | -12.85M | -13.81M | -19.12M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 9.91M | 33.59M | 41.36M | 27.32M | 19.22M |
| Total Liabilities | 2.76M | 3.12M | 5.89M | 4.51M | 5.43M |
| Total Equity | 7.15M | 30.47M | 35.47M | 22.81M | 13.8M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -9.43M | -17.33M | -12.34M | -20.04M | -12.61M |
| Investing | -17k | -10k | -89k | -36k | -6k |
| Financing | 3.98M | 36.69M | 16.31M | 124k | 9.22M |
| Market Cap | 14.5M |
| Price to Earnings Ratio | -1.27 |
| Price to Sales Ratio | 5.88 |
| Price to Cash Ratio | 1.92 |
| Price to Book Ratio | 1.75 |
| Dividend Yield | - |
| Shares Outstanding | 2.42B |
| Average Volume (1 week) | 7.09M |
| Average Volume (1 Month) | 17.21M |
| 52 Week Change | -25.00% |
| 52 Week High | 0.008 |
| 52 Week Low | 0.002 |
| Spread (Intraday) | 0 (16.67%) |
| Company Name | Alterity Therapeutics Ltd |
| Address |
level 3 melbourne, victoria 3053 |
| Website | https://www.alteritytherapeutics.com |
| Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
